These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15231627)

  • 1. Detection, verification, and quantification of adverse drug reactions.
    Stricker BH; Psaty BM
    BMJ; 2004 Jul; 329(7456):44-7. PubMed ID: 15231627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions: moving from chance to science.
    Haller C; James LP
    Clin Pharmacol Ther; 2011 Jun; 89(6):761-4. PubMed ID: 21593747
    [No Abstract]   [Full Text] [Related]  

  • 3. Surveying adverse event rates: lessons from a virosomal hepatitis A vaccine.
    Herzog C
    Expert Rev Vaccines; 2012 Apr; 11(4):383-5. PubMed ID: 22551020
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacovigilance--a commitment of medical professional.
    Daga S
    J Indian Med Assoc; 2008 Dec; 106(12):775. PubMed ID: 19370945
    [No Abstract]   [Full Text] [Related]  

  • 5. [The safety of pharmacotherapy in the light of monitoring adverse drug reaction].
    Jabłecka A; Korzeniowska K
    Przegl Lek; 2010; 67(10):1091-2. PubMed ID: 21360968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using computer technology to detect, measure, and prevent adverse drug events.
    Gardner RM; Evans RS
    J Am Med Inform Assoc; 2004; 11(6):535-6. PubMed ID: 15317740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring].
    Yang YY; Dong Z; Xia YP
    Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(21):3329-33. PubMed ID: 23397739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug safety: reporting systems for the general public.
    Raine JM
    BMJ; 2012 Aug; 345():e4916. PubMed ID: 22872709
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug reactions and reporting.
    Witte R
    Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
    [No Abstract]   [Full Text] [Related]  

  • 10. Active surveillance of serious adverse drug reactions in New Zealand children.
    Kunac D; Tatley MV; Grimwood K; Reith DM
    Arch Dis Child; 2012 Aug; 97(8):761-2. PubMed ID: 22563042
    [No Abstract]   [Full Text] [Related]  

  • 11. New EU drug safety committee ends national reporting of drug reactions.
    Watson R
    BMJ; 2012 Jul; 345():e4690. PubMed ID: 22777561
    [No Abstract]   [Full Text] [Related]  

  • 12. Surveillance of radiopharmaceuticals in Latin American: an alert.
    Santos-Oliveira R; Smith SW; de Souza Albernaz M; Bordim JA; Antunes LJ
    Rev Esp Med Nucl; 2011; 30(2):134-6. PubMed ID: 21334775
    [No Abstract]   [Full Text] [Related]  

  • 13. New FDA regulation to improve safety reporting in clinical trials.
    Sherman RB; Woodcock J; Norden J; Grandinetti C; Temple RJ
    N Engl J Med; 2011 Jul; 365(1):3-5. PubMed ID: 21651388
    [No Abstract]   [Full Text] [Related]  

  • 14. [Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward].
    Tribiño G; Maldonado C; Segura O; Díaz J
    Biomedica; 2006 Mar; 26(1):31-41. PubMed ID: 16929901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short patent lives jeopardize drug and patient safety.
    Hondeghem LM; De Clerck F; Camm J
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):353-7. PubMed ID: 18049301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Black box" warnings and drug surveillance.
    Menendez R
    J Allergy Clin Immunol; 2007 Mar; 119(3):759; author reply 759-60. PubMed ID: 17336622
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving how we evaluate the toxicity of approved drugs.
    Reidenberg MM
    Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adverse drug effects: involvement of physicians demanded].
    Hügler S
    Dtsch Med Wochenschr; 2009 Apr; 134(17):p16. PubMed ID: 19399721
    [No Abstract]   [Full Text] [Related]  

  • 19. A statistics-based approach of contextualization for adverse drug events detection and prevention.
    Chazard E; Bernonville S; Ficheur G; Beuscart R
    Stud Health Technol Inform; 2012; 180():766-70. PubMed ID: 22874295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should we react to adverse drug reactions?
    Ferner RE; Beard K
    Postgrad Med J; 2011 Feb; 87(1024):81-2. PubMed ID: 21303818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.